Podocyte Induction Medium Differentiation Protocol
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating podocytes from human pluripotent stem cells are poorly reproducible and lack specificity, failing to direct differentiation effectively into mature, functional podocytes, which are crucial for kidney disease modeling and therapeutic applications.
Innovation Solution
A novel podocyte induction medium comprising activin A, bone morphogenetic protein, an inhibitor of glycogen synthase kinase 3, vascular endothelial growth factor, and retinoic acid efficiently directs the differentiation of pluripotent stem cells into mature podocytes, with mechanical forces enhancing differentiation and interaction with endothelial cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If non-specific differentiation methods are used to generate podocytes from hPS cells, then cell production is achieved, but the differentiation is poorly reproducible and lacks specificity
Solution Approach 1:
The differentiation process is divided into distinct sequential stages: mesoderm induction, intermediate mesoderm formation, and podocyte differentiation. Each stage uses specific growth factor combinations and timeframes, transforming a poorly reproducible single-step process into a controlled multi-stage protocol with defined transition points and marker expression milestones.
Solution Approach 2:
The protocol systematically varies multiple parameters including growth factor concentrations (activin A, BMP4, VEGF, retinoic acid), culture timepoints, and medium compositions across different differentiation stages. These controlled parameter changes enable precise directional differentiation while ensuring reproducibility through standardized conditions at each transition point.
2Manufacturing precision
If existing differentiation methods are used, then podocyte-like cells are generated, but they exhibit immature phenotype and pseudo-podocyte characteristics
Solution Approach 1:
The protocol includes preliminary mesoderm induction and intermediate mesoderm formation stages before final podocyte differentiation. This preliminary action establishes proper cellular priming and transcriptional programming, ensuring that subsequent podocyte differentiation produces mature phenotypes with appropriate marker expression (podocin, nephrin, WT1) rather than immature pseudo-podocytes.
Solution Approach 2:
The differentiation protocol maintains continuous exposure to specific growth factor combinations and signaling pathways throughout all stages, ensuring uninterrupted maturation signals. This continuous action prevents premature termination of differentiation and ensures complete phenotypic maturation, producing functionally accurate podocytes with proper slit diaphragm formation and filtration characteristics.
3Productivity
If hPS cells are differentiated into podocytes for therapeutic applications, then cell supply is established, but the ability to direct differentiation specifically into podocytes is lacking
Solution Approach 1:
The protocol uses a universal combination of growth factors and signaling molecules (activin A, BMP4, VEGF, retinoic acid) that can be applied to different hPS cell lines and sources. This multi-functional approach simultaneously achieves mesoderm induction, intermediate mesoderm formation, and podocyte differentiation, providing a standardized manufacturing platform that yields functional podocytes regardless of the starting hPS cell source.
Data Source
AI summary
Embodiments of various aspects described herein relate to methods, kits, and cell culture media for generation of podocytes from pluripotent stem (PS) cells, as well as cells produced by the same, and methods of use.